About Us Careers Contact Us

Home
Isotopic Labels
Deuterium
1-Boc-4-(6-aminopyridin-3-yl)piperazine-[d4]

Inquiry List

* Name:
* Phone:
* Service & Products of Interested: [Deuterium] 1-Boc-4-(6-aminopyridin-3-yl)piperazine-[d4] (1808106-94-6)
Project Description:
* Quantity
* Email:
* Organization We recommend you to leave us your work email address so that we can serve you better. Please leave your organization information here if you don't have a work email address.
* Verification Code:

Our Highlights

Optimal Prices
Buying products on this site guarantees the best price
Flexible Batches
Flexible batch size to meet different needs of global customers
Prompt Delivery
Warehouses in multiple cities to ensure timely delivery
Quality Assurance
Strict process parameter control to ensure product quality
One-to-one Customization
One-to-one custom synthesis for special structural needs

Application Area

Environmental

Stable isotope-labeled compounds are used as environmental pollutant standards for the detection of air, water, soil, sediment and food.

Clinical diagnostic

In addition to treating various diseases, isotopes are used for imaging, diagnosis, and newborn screening.

Organic Chemistry

Small molecule compounds labeled with stable isotopes can be used as chemical reference for chemical identification, qualitative, quantitative, detection, etc. Various types of NMR solvents can be used to study the structure, reaction mechanism and reaction kinetics of compounds.

Metabolic Research

Stable isotope labeling allows researchers to study metabolic pathways in vivo in a safe manner.

1-Boc-4-(6-aminopyridin-3-yl)piperazine-[d4]

Inquiry

General Information
Catalog: BLP-021036
CAS: 1808106-94-6
Molecular Formula: C14H18D4N4O2
Molecular Weight: 282.37

Chemical Structure

Description	1-Boc-4-(6-aminopyridin-3-yl)piperazine-d4 is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
Synonyms	4-(6-Aminopyridin-3-yl)piperazine-1-carboxylic Acid tert-Butyl Ester-d4; 4-(6-Aminopyridin-3-yl)piperazine-1-carboxylic Acid tert-Butyl Ester-d4; tert-Butyl 4-(6-Amino-3-pyridyl)piperazine-1-carboxylate-d4; tert-Butyl 4-(6-Aminopyridin-3-yl)piperazine-1-carboxylate-d4
Solubility	Dichloromethane, Ethyl Acetate, Methanol
Appearance	Brown Solid